Including obesity drugs among the WHO’s essential medicines could have great significance for that population. Experts say that adding HIV drugs to the list in 2002 helped to make them much more ...
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, launched an ...
A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF ...
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, on Wednesday launched an investigation into the “outrageously high prices” of Novo ...
That's because the U.S. Food and Drug ... drugs when prescribed for obesity," KFF said in a news release. How the FDA's change affects Medicare spending will depend in part on how many Part D ...
Medscape Medical News, April 17, 2024 Amino Acid Supplement Cuts Liver Risks in PCOS and Obesity A proprietary essential amino ... Week in Cardiology Obesity drugs as ASCVD-modifiers, HR monitors ...
Revlimid and Avastin — and anti-diabetic and obesity drugs — Victoza, Januvia and Trulicity, among others — are nearing patent expiration. Some other high-selling drugs in the list include Stelara, a ...
DRUGMAKERS DOMINATE TOP LOBBYING SPENDERS — The pharmaceutical industry bolstered its lobbying spending in the first three months of 2024 compared with the same period in 2023, according to newly ...
For years, Kasia Lipska, MD, MHS, associate professor of medicine (endocrinology) at Yale School of Medicine (YSM), has been ...
Large and small drugmakers are vying for a piece of what analysts view as one of the biggest market opportunities in the pharma industry's history. Here’s what’s coming next.